| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.93B | +9.6% |
| Gross Profit | $1.84B | +7.6% |
| R&D Expense | $299.0M | +10.3% |
| SG&A Expense | $724.0M | +7.4% |
| Operating Income | $528.0M | +6.0% |
| Interest Expense | $212.0M | -25.4% |
| Pre-tax Income | $304.0M | +68.9% |
| Income Tax | $9.0M | +190.0% |
| Net Income | $295.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $418.0M | -0.5% |
| Accounts Receivable | $651.0M | +5.9% |
| Inventory | $921.0M | +3.1% |
| Current Assets | $2.51B | +1.5% |
| Total Assets | $8.80B | +2.4% |
| Current Liabilities | $927.0M | +19.6% |
| Long-term Debt | $4.15B | -7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $645.0M | +22.2% |
| Capital Expenditures | $148.0M | +25.4% |
| Investing Cash Flow | -$145.0M | -23.9% |
| Financing Cash Flow | -$562.0M | -2.4% |
| Free Cash Flow | $497.0M | +21.2% |
| +55.3% |
| EPS (Basic) | $4.39 | +55.7% |
| EPS (Diluted) | $4.37 | +55.5% |
| Total Liabilities |
| $6.08B |
| -3.0% |
| Stockholders' Equity | $2.72B | +17.1% |